Weed (BUDZ) Return on Capital Employed Growth (3y) (2021 - 2026)
Weed (BUDZ) Return on Capital Employed Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.96 Bn | 43.00 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.23 Bn | 39.58 Bn | 2.15 Bn | 1,036.00 |
| 3 | Zoetis | 31.76 Bn | 30.08 Bn | 1.05 Bn | 175.00 |
| 4 | Takeda Pharmaceutical | 28.68 Bn | 22.88 Bn | 5.10 Bn | 120.00 |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 434.00 |
| 6 | Viatris | 18.69 Bn | 17.81 Bn | 1.46 Bn | -295.00 |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | 1,076.00 |
| 8 | Elanco Animal Health | 11.78 Bn | 11.25 Bn | 798.00 Mn | 1,898.00 |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | - |
| 10 | Weed | 2.88 Mn | 2.88 Mn | - | -86,847.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 109,658.00 |
| Dec 31, 2025 | 45,047.00 |
| Sep 30, 2025 | 28,600.00 |
| Jun 30, 2025 | 36,828.00 |
| Mar 31, 2025 | 90,806.00 |
| Dec 31, 2024 | 69,672.00 |
| Sep 30, 2024 | 82,648.00 |
| Jun 30, 2024 | -71,877.00 |
| Mar 31, 2024 | -6,988.00 |
| Dec 31, 2023 | 28,375.00 |
| Sep 30, 2023 | 56,303.00 |
| Jun 30, 2023 | 225,399.00 |
| Mar 31, 2023 | 76,747.00 |
| Dec 31, 2022 | 157,463.00 |
| Sep 30, 2022 | 158,115.00 |
| Jun 30, 2022 | 138,825.00 |
| Mar 31, 2022 | 74,943.00 |
| Dec 31, 2021 | 48,761.00 |
| Sep 30, 2021 | 44,133.00 |